Dashboard
Manage Tickers

TIL Instil Bio, Inc.

Nasdaq instilbio.com


$ 14.02 $ -0.78 (-5.27 %)    

Thursday, 13-Nov-2025 10:57:31 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.41 $ -6.27 (-1.02 %)
DIA $ 479.30 $ -2.07 (-0.43 %)
SPY $ 675.90 $ -4.58 (-0.67 %)
TLT $ 89.77 $ -0.03 (-0.03 %)
GLD $ 386.93 $ -0.35 (-0.09 %)
$ 14.99
$ 14.55
$ 13.95 x 100
$ 14.45 x 63
$ 14.00 - $ 15.23
$ 10.80 - $ 42.79
82,098
na
101.66M
$ 3.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-13-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-04-2025 01-01-1970 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-21-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-31-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-07-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

instil-bio-q3-adj-eps-175-beats-235-estimate
Instil Bio Q3 Adj. EPS $(1.75) Beats $(2.3...
11/13/2025 12:11:05

Instil Bio (NASDAQ:TIL) reported quarterly losses of $(1.75) per share which beat the analyst consensus estimate of $(2.35) by ...

hc-wainwright--co-reiterates-buy-on-instil-bio-maintains-125-price-target
HC Wainwright & Co. Reiterates Buy on Inst...
09/11/2025 13:30:49

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $125 price ta...

instil-bio-says-immuneonco-biopharma-presents-preliminary-efficacy-and-safety-data-of-2510-as-monotherapy-in-phase-1-study-of-patients-in-china-with-previously-treated-sq-nsclc-at-2025-wclc
Instil Bio Says ImmuneOnco Biopharma Prese...
09/10/2025 11:13:13

ORR of 35% in previously treated squamous NSCLC patients with responses across PD-L1 TPS scoresDifferentiated structure of ‘251...

hc-wainwright--co-reiterates-buy-on-instil-bio-maintains-125-price-target
HC Wainwright & Co. Reiterates Buy on Inst...
08/27/2025 11:10:34

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $125 price ta...

hc-wainwright--co-reiterates-buy-on-instil-bio-maintains-125-price-target
HC Wainwright & Co. Reiterates Buy on Inst...
08/15/2025 11:24:45

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $125 price ta...

instil-bio-q2-adj-eps-288-misses-250-estimate-cash-cash-equivalents-restricted-cash-marketable-securities-and-long-term-investments-of-1036m-will-enable-the-company-to-fund-its-operating-plan-beyond-2026
Instil Bio Q2 Adj. EPS $(2.88) Misses $(2....
08/13/2025 10:15:18

instil-bio-notes-that-immuneonco-reported-80-partial-response-in-squamous-nsclc-from-phase-2-trial-of-pd-l1xvegf-bispecific-imm2510-with-chemo-no-dose-limiting-toxicities-observed
Instil Bio Notes That ImmuneOnco Reported ...
07/31/2025 10:09:03

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/02/2025 12:06:54

instil-bio-gets-us-fda-clearance-for-ind-of-axn-2510-a-pd-l1xvegf-bispecific-antibody-with-phase-1-solid-tumor-trial-set-for-2025
Instil Bio Gets US FDA Clearance For IND O...
07/02/2025 10:02:06

hc-wainwright--co-reiterates-buy-on-instil-bio-maintains-125-price-target
HC Wainwright & Co. Reiterates Buy on Inst...
06/05/2025 11:23:09

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $125 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
06/02/2025 21:05:57

jmp-securities-reiterates-market-perform-on-instil-bioto-market-perform
JMP Securities Reiterates Market Perform o...
06/02/2025 15:35:22

JMP Securities analyst Reni Benjamin reiterates Instil Bio (NASDAQ:TIL) from Market Perform to Market Perform.

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
06/02/2025 12:07:43

instil-and-immuneonco-to-present-clinical-trial-updates-and-insights-on-pd-l1xvegf-at-asco-meeting
Instil And ImmuneOnco To Present Clinical ...
05/23/2025 11:05:07

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/22/2025 17:06:46

hc-wainwright--co-maintains-buy-on-instil-bio-lowers-price-target-to-105
HC Wainwright & Co. Maintains Buy on Insti...
05/22/2025 11:21:47

HC Wainwright & Co. analyst Mitchell Kapoor maintains Instil Bio (NASDAQ:TIL) with a Buy and lowers the price target fro...

instil-bio-immuneonco-advance-lung-cancer-drug-2510-with-new-trials-in-china-and-us-plans-ahead
Instil Bio, ImmuneOnco Advance Lung Cancer...
05/22/2025 10:04:14

Instil Bio, Inc. (NASDAQ:TIL, ", Instil", ))) and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, &#...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/20/2025 12:08:41

why-pegasystems-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket
Why Pegasystems Shares Are Trading Higher ...
05/20/2025 09:43:58

instil-bio-q1-adj-eps-132-beats-259-estimate
Instil Bio Q1 Adj. EPS $(1.32) Beats $(2.5...
05/13/2025 11:09:26

Instil Bio (NASDAQ:TIL) reported quarterly losses of $(1.32) per share which beat the analyst consensus estimate of $(2.59) by ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION